Skip to main content

The Next Generation

of Neurological Treatment

With our cutting-edge technology, we’re revolutionizing the efficacy of therapeutic agents for the management of brain tumors and a variety of neurological conditions.

Embarking on a mission to improve patient outcomes, we’re navigating the final frontier of treating the human brain with groundbreaking Brain-Computer Interface (BCI) technology.

Our Vision

At NeuraSeed BCI, we firmly believe that the future of brain cancer and neurological disorder treatments lies in taking BCI technology into the previously uncharted deep brain.

This bold step forward holds immense potential, promising innovative solutions and hope for those battling these challenging conditions.

Our Tech

With patent-pending novel integrated BCI and microfluidic device technology, we are striving to increase the efficacy of chemotherapy, immunotherapy and other neurotherapeutic agents for the treatment of brain tumors and other neurological disorders.

Our Team

Led by world-class neurosurgeons, our multidisciplinary team incorporates clinical and basic neurosciences with biomedical and electrical engineering to revolutionize our understanding and ability to treat a variety of neurological conditions.

Our scientific trailblazers are pioneering a new era in healthcare using cutting-edge BCI technology designed to provide targeted dosing and real-time monitoring for better patient outcomes.